{"id":36822,"date":"2025-07-07T14:14:25","date_gmt":"2025-07-07T06:14:25","guid":{"rendered":"https:\/\/flcube.com\/?p=36822"},"modified":"2025-07-07T14:14:26","modified_gmt":"2025-07-07T06:14:26","slug":"bgi-genomics-launches-mini-breast-cancer-76-gene-detection-system-for-personalized-treatment","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=36822","title":{"rendered":"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment"},"content":{"rendered":"\n<p>China-based BGI Genomics Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/300676:SHE\">SHE: 300676<\/a>) announced the launch of its mini breast cancer 76-gene detection system. This innovative solution offers personalized treatment guidance for breast cancer patients through a single test that covers genetic risk assessment, targeted therapy, immunotherapy, and chemotherapy drug recommendations.<\/p>\n\n\n\n<p><strong>Comprehensive Biomarker Analysis<\/strong><br>The system simultaneously analyzes critical biomarkers including *AKT, PIK3CA, PTEN, ESR1, BRCA1\/2, HER2, and NTRK. It evaluates targeted drug efficacy, assesses endocrine therapy resistance risk, determines PARP inhibitor suitability, and identifies drug resistance mechanisms. The product supports both tumor tissue and ctDNA testing to enhance accuracy and broaden clinical applicability.<\/p>\n\n\n\n<p><strong>Clinical and Hereditary Applications<\/strong><br>Beyond providing clinical therapy references, the system aids in the screening of BRCA and other high-risk hereditary genes, enabling family risk assessment. As part of BGI&#8217;s solid tumor detection series, this advancement aims to enhance precision oncology for breast cancer and nine other prevalent cancers.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based BGI Genomics Co., Ltd (SHE: 300676) announced the launch of its mini breast cancer&#8230;<\/p>\n","protected":false},"author":1,"featured_media":36823,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[500,16,109,1243],"class_list":["post-36822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-bgi-genomics","tag-cancer","tag-precision-medicine","tag-she-300676"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based BGI Genomics Co., Ltd (SHE: 300676) announced the launch of its mini breast cancer 76-gene detection system. This innovative solution offers personalized treatment guidance for breast cancer patients through a single test that covers genetic risk assessment, targeted therapy, immunotherapy, and chemotherapy drug recommendations.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=36822\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment\" \/>\n<meta property=\"og:description\" content=\"China-based BGI Genomics Co., Ltd (SHE: 300676) announced the launch of its mini breast cancer 76-gene detection system. This innovative solution offers personalized treatment guidance for breast cancer patients through a single test that covers genetic risk assessment, targeted therapy, immunotherapy, and chemotherapy drug recommendations.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=36822\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-07T06:14:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-07T06:14:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0706.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment\",\"datePublished\":\"2025-07-07T06:14:25+00:00\",\"dateModified\":\"2025-07-07T06:14:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822\"},\"wordCount\":164,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0706.webp\",\"keywords\":[\"BGI Genomics\",\"Cancer\",\"Precision medicine\",\"SHE: 300676\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=36822#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=36822\",\"name\":\"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0706.webp\",\"datePublished\":\"2025-07-07T06:14:25+00:00\",\"dateModified\":\"2025-07-07T06:14:26+00:00\",\"description\":\"China-based BGI Genomics Co., Ltd (SHE: 300676) announced the launch of its mini breast cancer 76-gene detection system. This innovative solution offers personalized treatment guidance for breast cancer patients through a single test that covers genetic risk assessment, targeted therapy, immunotherapy, and chemotherapy drug recommendations.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=36822\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0706.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/0706.webp\",\"width\":1080,\"height\":608,\"caption\":\"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=36822#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment - Insight, China&#039;s Pharmaceutical Industry","description":"China-based BGI Genomics Co., Ltd (SHE: 300676) announced the launch of its mini breast cancer 76-gene detection system. This innovative solution offers personalized treatment guidance for breast cancer patients through a single test that covers genetic risk assessment, targeted therapy, immunotherapy, and chemotherapy drug recommendations.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=36822","og_locale":"en_US","og_type":"article","og_title":"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment","og_description":"China-based BGI Genomics Co., Ltd (SHE: 300676) announced the launch of its mini breast cancer 76-gene detection system. This innovative solution offers personalized treatment guidance for breast cancer patients through a single test that covers genetic risk assessment, targeted therapy, immunotherapy, and chemotherapy drug recommendations.","og_url":"https:\/\/flcube.com\/?p=36822","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-07T06:14:25+00:00","article_modified_time":"2025-07-07T06:14:26+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0706.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=36822#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=36822"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment","datePublished":"2025-07-07T06:14:25+00:00","dateModified":"2025-07-07T06:14:26+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=36822"},"wordCount":164,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=36822#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0706.webp","keywords":["BGI Genomics","Cancer","Precision medicine","SHE: 300676"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=36822#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=36822","url":"https:\/\/flcube.com\/?p=36822","name":"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=36822#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=36822#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0706.webp","datePublished":"2025-07-07T06:14:25+00:00","dateModified":"2025-07-07T06:14:26+00:00","description":"China-based BGI Genomics Co., Ltd (SHE: 300676) announced the launch of its mini breast cancer 76-gene detection system. This innovative solution offers personalized treatment guidance for breast cancer patients through a single test that covers genetic risk assessment, targeted therapy, immunotherapy, and chemotherapy drug recommendations.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=36822#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=36822"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=36822#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0706.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0706.webp","width":1080,"height":608,"caption":"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=36822#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/0706.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/36822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=36822"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/36822\/revisions"}],"predecessor-version":[{"id":36824,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/36822\/revisions\/36824"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/36823"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=36822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=36822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=36822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}